Skip to content

Company information lookup

IMMURON LIMITED (IMC)

Immuron is a biopharmaceutical company focused on oral immunotherapy treatments using dairy-derived antibody products for humans relating to gastrointestinal health, liver diseases such as fatty liver/NASH and infectious diseases such as Clostridium difficile

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
IMC 0.200 0% 0.185 0.200 0.000 0.000 0.000 0
(Status - RE)

IMMURON LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code IMC
Securities
Official Listing Date 30 April, 1999
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.immuron.com
Registered Office Address Suite 1, 1233 High Street, ARMADALE, VIC, AUSTRALIA, 3143
Head Office Telephone 03 9824 5254
Head Office Fax 03 9822 7735
Share Registry SECURITY TRANSFER REGISTRARS PTY. LIMITED
770 CANNING HIGHWAY, APPLECROSS, WA, AUSTRALIA, 6153
Share Registry Telephone (08) 9315 2333
Directors / Senior Management
Dr Roger Aston (Non Exec. Chairman)
Mr Amos Meltzer (CEO)
Mr Stephen Anastasiou (Non Exec. Director)
Mr Daniel Jude Pollock (Non Exec. Director)
Company Secretary Mr Peter Vaughan (Joint Co. Secretary)
Mr Phillip Hains (Joint Co. Secretary)
Principal Activities Immuron is a biopharmaceutical company focused on oral immunotherapy treatments using dairy-derived antibody products for humans relating to gastrointestinal health, liver diseases such as fatty liver/NASH and infectious diseases such as Clostridium difficile

IMMURON LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
18/12/2014 asterix Resignation of CEO 1 PDF
27/11/2014   Ethics Approval Secured in all Australian NASH Trial Sites 1 PDF
27/11/2014   Immuron to Recommence Trading as IMC 1 PDF
21/11/2014   Appendix 3B and 708A 10 PDF
20/11/2014 asterix Immuron Completes Capital Consolidation 1 PDF
13/11/2014   Results of Annual General Meeting 1 PDF
13/11/2014   2014 Annual General Meeting CEO Presentation 22 PDF
15/10/2014 asterix NASH & ASH Clinical Trial Update 2 PDF
14/10/2014   Notice of Annual General Meeting - 13 Nov 2014 23 PDF
02/09/2014 asterix Immuron Improves Hadasit Royalty Terms 1 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
19 Dec 2014 0.200 -4.76% 0.200 0.175 68,500
16 Dec 2014 0.210 5% 0.210 0.200 8,952
15 Dec 2014 0.200 5.26% 0.200 0.190 93,418
12 Dec 2014 0.190 -5% 0.200 0.190 52,619
11 Dec 2014 0.200 0% 0.200 0.200 70,011

* Volume of shares shown represents only those shares traded on ASX.

IMMURON LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security IMC. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security IMC

Warrants & Structured Products

No warrants & Structured Products are available over the security IMC